Endocrinology

Director: Sharon E. Oberfield, MD		Tel: (212) 305-6559
Administrator: William Vasquez		Fax: (212) 305-4778

The Division of Pediatric Endocrinology, Diabetes and Metabolism is a one-of-a-kind resource for Pediatric Endocrine research and clinical services.

Our mission is to provide excellence in clinical care and patient safety, and to allow for growth in the arenas of training and education, and patient-oriented research in pediatric endocrine disorders. With our fellows and attendings we provide consultative care to patients with endocrine disorders both in the in and out-patients settings. Since its opening in 1998 our faculty and fellows also provide care to children and adolescents with Diabetes at the Naomi Berrie Diabetes Center (NBDC) under the co-directorship of Drs. Robin Goland and Rudolph Leibel. The strengths of the Naomie Berrie Diabetes Center include the close collaboration between its clinical and research programs, collaboration between clinicians from diverse specialties working together to care for both adult patients and pediatric patients as well as the great ethnic and socioeconomic diversity of its patient population.

This year alone the Division of Pediatric Endocrinology, Diabetes and Metabolism had over 7000 outpatient visits and more than 200 in-house consultations. We also perform over 200 diagnostic endocrine tests per year in our Endocrine Testing Service. We are a designated site for the NY State Congenital Adrenal Hyperplasia and Newborn Thyroid Screening Program. We have an active fellowship program that is supported in part by our NIH T32 training grant. Our educational initiatives are to: To train the future physician-scientists and academic leaders in Pediatric Endocrinology, Diabetes and Metabolism, fund young researchers working in basic science and patient oriented research and train physicians in family based, patient centered clinical services.

Our division is actively involved in multiple research protocols funded by the NIH, foundations, philantrophy and pharmaceutical companies. Our research highlights include: Studies of alterations in androgen metabolism, growth factors and insulin sensitivity in children at risk for Metabolic Syndrome and Type 2 diabetes, initiation of new treatments for growth failure and disordered puberty, studies assessing the effect of exercise/bariatric surgery in morbidly obese adolescents and evaluation of body composition in children, including assessment of fat content of muscle cells as it relates to insulin resistance.

We maintain active cross disciplinary collaborations with the Naomi Berrie Center and The Center for Adolescent Bariatric Surgery Program to facilitate many of these investigations.